Related Experiment Video
Updated: Jul 19, 2026
10:14
Telomerase Activity in the Various Regions of Mouse Brain: Non-Radioactive Telomerase Repeat Amplification Protocol (TRAP) Assay
Published on: September 2, 2014
Telomerase reverse transcriptase (TERT) expression and proliferation in canine brain tumours
1Institute for Comparative Medicine, University of Glasgow Veterinary School, UK. longsn@vet.upenn.edu
Neuropathology and Applied Neurobiology
|November 7, 2006
Summary
Canine brain tumors show significant telomerase reverse transcriptase (TERT) expression, correlating with tumor grade and proliferation markers. This supports using dogs for developing new telomerase-based cancer therapies.
Area of Science:
- Oncology
- Molecular Biology
- Veterinary Medicine
Background:
- Telomerase, a key enzyme in cell immortality, is a promising target for anticancer therapies.
- The dog is a validated preclinical model for evaluating telomerase-based treatments.
- Telomerase expression is prevalent in human cancers but absent in most normal cells.
Purpose of the Study:
- To analyze telomerase reverse transcriptase (TERT) expression in canine brain tumors.
- To investigate the correlation between TERT expression, histological grade, and proliferation markers (MIB-1) in these tumors.
- To further validate the dog as a model for preclinical studies of telomerase-based brain tumor therapeutics.
Main Methods:
- Immunohistochemistry was used to detect TERT expression in 93 canine brain tumors.
- TERT immunoreactivity was quantified and statistically analyzed against tumor grade.
- MIB-1 labeling index (LI) was assessed in a subset of tumors and correlated with TERT expression and tumor grade.
Main Results:
- TERT immunoreactivity was detected in 32% of grade 1 and 67.4% of grade 2 canine brain tumors, showing a significant association with histological grade (P = 0.00012).
- The MIB-1 labeling index significantly correlated with tumor grade, with higher MIB-1 LI in grade 2 tumors (21.7%) compared to grade 1 (1.5%) (P << 0.001).
- A significant association was found between MIB-1 LI and TERT expression across all analyzed brain tumors (P << 0.001).
Conclusions:
- Canine brain tumors exhibit TERT expression that significantly correlates with tumor grade and proliferation.
- These findings reinforce the utility of the dog as a relevant preclinical model for developing novel telomerase-targeted brain tumor therapies.
- The study provides further evidence supporting the dog's role in advancing anticancer drug development for brain malignancies.
Related Concept Videos
02:15Replicative Cell Senescence
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
02:41Telomeres and Telomerase
In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded DNA.